Microbiome. 2019 Feb 26;7(1):31. doi: 10.1186/s40168-019-0620-y.
The National Institutes of Health (NIH) is the primary federal government agency for biomedical research in the USA. NIH provides extensive support for human microbiome research with 21 of 27 NIH Institutes and Centers (ICs) currently funding this area through their extramural research programs. This analysis of the NIH extramural portfolio in human microbiome research briefly reviews the early history of this field at NIH, summarizes the program objectives and the resources developed in the recently completed 10-year (fiscal years 2007-2016) $215 M Human Microbiome Project (HMP) program, evaluates the scope and range of the $728 M NIH investment in extramural human microbiome research activities outside of the HMP over fiscal years 2012-2016, and highlights some specific areas of research which emerged from this investment. This analysis closes with a few comments on the technical needs and knowledge gaps which remain for this field to be able to advance over the next decade and for the outcomes of this research to be able to progress to microbiome-based interventions for treating disease and supporting health.
美国国立卫生研究院(NIH)是美国生物医学研究的主要联邦政府机构。NIH 通过其院外研究计划为人类微生物组研究提供了广泛的支持,目前 27 个 NIH 研究所和中心(ICs)中有 21 个正在资助这一领域。对 NIH 院外人类微生物组研究组合的分析简要回顾了 NIH 这一领域的早期历史,总结了该计划的目标以及在最近完成的为期 10 年(2007-2016 财年)2.15 亿美元人类微生物组计划(HMP)中开发的资源,评估了 2012-2016 财年 NIH 对 HMP 以外的院外人类微生物组研究活动的 7.28 亿美元投资的范围和范围,并突出了从这项投资中出现的一些具体研究领域。最后,对该领域在未来十年内取得进展以及该研究成果能够推进基于微生物组的疾病治疗和健康支持干预措施所需要的技术需求和知识差距进行了简要评论。